LINCOLN, Neb., May 31, 2023 (GLOBE NEWSWIRE) -- NRC Health announces it is the Platinum Partner for The Patient Experience Symposium taking place in Boston, Sept. 18-20. The event, hosted by ICD Media Group, is an in-depth conference for senior-level healthcare executives and practitioners focused on improving the overall patient experience.
The healthcare industry is going through a transformation. Patients are more informed, have more choices, and are demanding better consistency and quality of care. To that end, the Patient Experience Symposium brings together the most influential industry thought leaders to exchange ideas and workshop solutions to the most challenging patient pain points. The Symposium sessions will focus on helping healthcare ecosystems deliver better outcomes for patients, increasing workforce engagement, and lowering overall costs for the patient and the facility.
“Making every interaction with a patient throughout their healthcare journey more personal and informed not only improves patient outcomes but also improves caregivers’ resilience and an organization’s bottom-line success,” said Bill Doherty, President and Patient Experience Symposium Conference Director, ICD Media Group. “The Patient Experience Symposium is the premier event for healthcare leaders who are committed to improving the patient experience. We are very happy to have NRC Health join us as our Platinum Sponsor.”
NRC Health experts, including Chief Transformation Officer, Dr. Gregory Makoul, will share their knowledge and research at the conference, leading a panel, facilitating round table discussions, and connecting with delegates.
“We are proud to sponsor the Patient Experience Symposium,” said Dr. Gregory Makoul, Chief Transformation Officer at NRC Health. “NRC Health is intensely focused on humanizing healthcare through a person-centered approach. Conferences like this provide a unique opportunity for personalized engagement and are critical to advancing our mission to drive change across the healthcare ecosystem.”
This conference will follow NRC Health’s 29th Annual Conference, Human Understanding Beyond | HUB23 Aug. 9-11 in Boston. Registration for both events is now open.
About NRC Health
For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health’s patient-focused approach, unmatched market research, and emphasis on consumer preferences are transforming the healthcare experience, creating strong outcomes for patients and entire healthcare systems. NRC Health is ranked #1 for Patient Experience Improvement in the 2023 Best in KLAS report.
For more information, please email This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it..
About ICD Media Group
ICD Healthcare Conference Series curates the best practices in the healthcare industry and covers topics that are top of mind today. ICD offers high-quality conferences in a broad range of industries. Utilizing extensive detailed market research, ICD develops targeted events designed to encourage companies to send their entire teams to problem-solve, network, and brainstorm with other industry leaders, consultants, and suppliers.
Contact: Bill Doherty, Conference Director, This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.ICDhealth.net for more information.
Media Contact:
Stephanie Schultz
Stephanie@tippingpointcomm.com
262-370-1100
Last Trade: | US$17.76 |
Daily Change: | -0.08 -0.45 |
Daily Volume: | 50,447 |
Market Cap: | US$417.000M |
October 25, 2024 August 22, 2024 August 06, 2024 May 07, 2024 February 13, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB